Cargando…

Naturally Acquired Rift Valley Fever Virus Neutralizing Antibodies Predominantly Target the Gn Glycoprotein

Rift Valley fever (RVF) is a viral hemorrhagic disease first discovered in Kenya in 1930. Numerous animal studies have demonstrated that protective immunity is acquired following RVF virus (RVFV) infection and that this correlates with acquisition of virus-neutralizing antibodies (nAbs) that target...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wright, Daniel, Allen, Elizabeth R., Clark, Madeleine H.A., Gitonga, John N., Karanja, Henry K., Hulswit, Ruben J.G., Taylor, Iona, Biswas, Sumi, Marshall, Jennifer, Mwololo, Damaris, Muriuki, John, Bett, Bernard, Bowden, Thomas A., Warimwe, George M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588868/ https://www.ncbi.nlm.nih.gov/pubmed/33134899 http://dx.doi.org/10.1016/j.isci.2020.101669

Ejemplares similares

Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression
por: Phoenix, Inaia, et al.
Publicado: (2016)

Two monoclonal antibodies against glycoprotein Gn protect mice from Rift Valley Fever challenge by cooperative effects
por: Gutjahr, Benjamin, et al.
Publicado: (2020)

Association between Rift Valley fever virus seroprevalences in livestock and humans and their respective intra-cluster correlation coefficients, Tana River County, Kenya
por: Bett, B., et al.
Publicado: (2018)

N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGN
por: Phoenix, Inaia, et al.
Publicado: (2016)

Vaccine Efficacy of Self-Assembled Multimeric Protein Scaffold Particles Displaying the Glycoprotein Gn Head Domain of Rift Valley Fever Virus
por: Wichgers Schreur, Paul J., et al.
Publicado: (2021)

Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya
por: Gachohi, John M., et al.
Publicado: (2016)

Characterization of Two Neutralizing Antibodies against Rift Valley Fever Virus Gn Protein
por: Hao, Meng, et al.
Publicado: (2020)

Correction: Modelling Vaccination Strategies against Rift Valley Fever in Livestock in Kenya
por: Gachohi, John M., et al.
Publicado: (2017)

Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley Fever in adults: an open-label, non-randomised, first-in-human phase 1 clinical trial
por: Jenkin, Daniel, et al.
Publicado: (2023)

Clinical manifestations of Rift Valley fever in humans: Systematic review and meta-analysis
por: Anywaine, Zacchaeus, et al.
Publicado: (2022)

Systematic literature review of Rift Valley fever virus seroprevalence in livestock, wildlife and humans in Africa from 1968 to 2016
por: Clark, Madeleine H. A., et al.
Publicado: (2018)

Potency of a thermostabilised chimpanzee adenovirus Rift Valley Fever vaccine in cattle
por: Dulal, Pawan, et al.
Publicado: (2016)

A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep
por: Faburay, Bonto, et al.
Publicado: (2016)

Multifunctional human monoclonal antibody combination mediates protection against Rift Valley fever virus at low doses
por: Chapman, Nathaniel S., et al.
Publicado: (2023)

Development of Rift Valley fever (RVF) vaccine by genetic joining of the RVF-glycoprotein Gn with the strong adjuvant subunit B of cholera toxin (CTB) and expression in bacterial system
por: Ibrahim, Essam H., et al.
Publicado: (2019)

Genomic surveillance of Rift Valley fever virus: from sequencing to lineage assignment
por: Juma, John, et al.
Publicado: (2022)

The Pathogenesis of Rift Valley Fever
por: Ikegami, Tetsuro, et al.
Publicado: (2011)

Rift Valley Fever Encephalitis
por: Alrajhi, Abdulrahman A., et al.
Publicado: (2004)

Rift Valley Fever in Chad
por: Ringot, David, et al.
Publicado: (2004)

Vaccination with DNA Plasmids Expressing Gn Coupled to C3d or Alphavirus Replicons Expressing Gn Protects Mice against Rift Valley Fever Virus
por: Bhardwaj, Nitin, et al.
Publicado: (2010)

A systematic review of Rift Valley Fever epidemiology 1931–2014
por: Nanyingi, Mark O., et al.
Publicado: (2015)

Spatial, seasonal and climatic predictive models of Rift Valley fever disease across Africa
por: Redding, David W., et al.
Publicado: (2017)

Spatial and Temporal Pattern of Rift Valley Fever Outbreaks in Tanzania; 1930 to 2007
por: Sindato, Calvin, et al.
Publicado: (2014)

Predictive Factors and Risk Mapping for Rift Valley Fever Epidemics in Kenya
por: Munyua, Peninah M., et al.
Publicado: (2016)

Lay perceptions of risk factors for Rift Valley fever in a pastoral community in northeastern Kenya
por: Ng’ang’a, Caroline M., et al.
Publicado: (2016)

Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats
por: Stedman, Anna, et al.
Publicado: (2019)

Rift Valley Fever in Goats, Cameroon
por: LeBreton, Matthew, et al.
Publicado: (2006)

RIFT VALLEY FEVER: LESSONS TO BE LEARNED
por: Alam, Awatif A., et al.
Publicado: (2000)

Rift Valley Fever in Namibia, 2010
por: Monaco, Federica, et al.
Publicado: (2013)

A Protective Monoclonal Antibody Targets a Site of Vulnerability on the Surface of Rift Valley Fever Virus
por: Allen, Elizabeth R., et al.
Publicado: (2018)

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever
por: Warimwe, George M., et al.
Publicado: (2016)

Postharvest Storage Practices of Maize in Rift Valley and Lower Eastern Regions of Kenya: A Cross-Sectional Study
por: Koskei, Peter, et al.
Publicado: (2020)

A Rift Valley fever virus Gn ectodomain-based DNA vaccine induces a partial protection not improved by APC targeting
por: Chrun, Tiphany, et al.
Publicado: (2018)

Bacterium-Like Particles Displaying the Rift Valley Fever Virus Gn Head Protein Induces Efficacious Immune Responses in Immunized Mice
por: Zhang, Shengnan, et al.
Publicado: (2022)

Rift Valley Fever – epidemiological update and risk of introduction into Europe
por: Nielsen, Søren Saxmose, et al.
Publicado: (2020)

Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
por: Warimwe, George M, et al.
Publicado: (2013)

Public Health Benefits from Livestock Rift Valley Fever Control: A Simulation of Two Epidemics in Kenya
por: Kimani, Tabitha, et al.
Publicado: (2016)

Epidemiological Investigation of a Rift Valley Fever Outbreak in Humans and Livestock in Kenya, 2018
por: Hassan, Abdala, et al.
Publicado: (2020)

The 2007 Rift Valley Fever Outbreak in Sudan
por: Hassan, Osama Ahmed, et al.
Publicado: (2011)

Rift Valley Fever, Mayotte, 2007–2008
por: Sissoko, Daouda, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_k9dfpdv1k63qn6d9atvu7ppkqd